General Comments / Chat, page-8400

as you can see the good doctor thinks the triangle report was  extremely conservative on the valuation.
NOW Everyone should do their own calculation but if you add the shares on issue with the valuation of the triangle report and add some peak annual sales you will get. $245 a share to $490 a share.
and according to the post that is still quite conservative.
THATS CARDIO PROTECTION ONLY !!
then if you add FTO which most probably be worth more then cardio protection we have the potential to at least double that figure again.
Not including all other treatments they will find that we will possibly be used for.
Now I wish all that pans out  to the highest SP but I believe we will take an offer much lower personally.
Now when you do add all that I really won't be surprised if we do get an offer for a buyout anywhere between
$30 To $60 a share
That offer will be before we get confirmation of full results if we get results and confirmation that RAC is successful then they will have to pay top dollar.
Just my thoughts why I believe we will get an offer in my price range